Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
Clinical trial NCT01042041 · COMPLETED
Trial details
- NCT number
- NCT01042041
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.